Aimei Health Technology Co. Ltd. has announced the extension of its financial arrangement, enabling the company to further its business combination efforts. On July 6, 2025, Aimei Health Technology deposited an aggregate of $150,000 into its trust account, facilitating a one-month extension of its initial business combination period from July 6, 2025, to August 6, 2025. This extension is part of up to 12 extensions allowed under the company's Amended and Restated Articles of Association. Concurrently, Aimei Health issued an unsecured promissory note totaling $150,000 to its sponsor, Aimei Health Ltd., and United Hydrogen Group Inc., with each contributing $75,000. This note, which does not bear interest, is set to mature upon the company's consummation of a business combination with United Hydrogen. The involved parties retain the option to convert this note into private units of Aimei Health, consisting of ordinary shares and rights to additional shares, prior to the business combination's closing.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。